Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IIIB/IV”

1,447 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,447 results

Testing effectiveness (Phase 2)Ended earlyNCT02465957
What this trial is testing

QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC)

Who this might be right for
Stage IIIB Merkel Cell CarcinomaStage IV Merkel Cell Carcinoma
ImmunityBio, Inc. 7
Testing effectiveness (Phase 2)Study completedNCT00002475
What this trial is testing

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerColorectal CancerKidney Cancer+3 more
St. Vincent Medical Center - Los Angeles 40
Testing effectiveness (Phase 2)Study completedNCT00003565
What this trial is testing

Docetaxel in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerHead and Neck Cancer+2 more
Alliance for Clinical Trials in Oncology 109
Testing effectiveness (Phase 2)Study completedNCT02387099
What this trial is testing

Dose EScalation Induction of EvERolimus

Who this might be right for
Breast CancerHormone Receptor Positive Tumor
GBG Forschungs GmbH 156
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT00327535
What this trial is testing

Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy.

Who this might be right for
Anemia
Hoffmann-La Roche 153
Large-scale testing (Phase 3)Looking for participantsNCT06096844
What this trial is testing

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Who this might be right for
Advanced Lung Non-Small Cell CarcinomaStage IIIB Lung Cancer AJCC v8Stage IIIC Lung Cancer AJCC v8+1 more
National Cancer Institute (NCI) 304
Post-approval studies (Phase 4)Study completedNCT00249834
What this trial is testing

Safety and Efficacy of Pre-defined, Fixed Dose of Gonal-f Pen Based on Subject Baseline Characteristics in Subjects Undergoing in Vitro Fertilization (IVF)

Who this might be right for
Infertility
Merck KGaA, Darmstadt, Germany 166
Testing effectiveness (Phase 2)WithdrawnNCT00057993
What this trial is testing

Trastuzumab and Exemestane in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
Northwestern University
Testing effectiveness (Phase 2)Study completedNCT00283244
What this trial is testing

Ph II Gemcitabine, Erlotinib, and Gemcitabine With Erlotinib/Elderly Patients W/ IIIB/IV NSCLC

Who this might be right for
Lung Cancer
UNC Lineberger Comprehensive Cancer Center 147
Testing effectiveness (Phase 2)UnknownNCT03048500
What this trial is testing

Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage III Non-Small Cell Lung CancerStage IIIA Non-Small Cell Lung Cancer+2 more
Northwestern University 17
Large-scale testing (Phase 3)Ended earlyNCT00097344
What this trial is testing

The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

Who this might be right for
Breast NeoplasmsNeoplasms, Hormone-Dependent
Intarcia Therapeutics 842
Testing effectiveness (Phase 2)Study completedNCT00660816
What this trial is testing

Pemetrexed or Docetaxel With or Without Erlotinib in Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Case Comprehensive Cancer Center 46
Early research (Phase 1)Ended earlyNCT01212887
What this trial is testing

Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+4 more
Cancer Research UK 14
Large-scale testing (Phase 3)Ended earlyNCT00738387
What this trial is testing

ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Novartis Pharmaceuticals 900
Testing effectiveness (Phase 2)UnknownNCT04248387
What this trial is testing

Toripalimab in the Neoadjuvant Treatment of BRAF V600 Wild Type Melanoma

Who this might be right for
Melanoma Stage IIIB-IV
Fudan University 100
Not applicableLooking for participantsNCT04723095
What this trial is testing

Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix

Who this might be right for
Cervical Large Cell Neuroendocrine CarcinomaCervical Neuroendocrine CarcinomaCervical Small Cell Carcinoma+19 more
M.D. Anderson Cancer Center 750
Testing effectiveness (Phase 2)Active Not RecruitingNCT03225664
What this trial is testing

Trametinib and Pembrolizumab in Treating Patients With Recurrent Non-small Cell Lung Cancer That Is Metastatic, Unresectable, or Locally Advanced

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8+7 more
M.D. Anderson Cancer Center 37
Testing effectiveness (Phase 2)Looking for participantsNCT04616209
What this trial is testing

Allogeneic PB103 (NK Cells) Therapy in Non-small Cell Lung Cancer (NSCLC) Patients

Who this might be right for
Non-small Cell Lung Cancer
Precision Biotech Taiwan Corp. 24
Not applicableStudy completedNCT01012401
What this trial is testing

Evaluating an Interactive Cancer Communication System (ICCS) in Lung Cancer

Who this might be right for
Lung Cancer, Stage IIIb or IV
University of Wisconsin, Madison 284
Load More Results